Sagimet Biosciences Inc - Ordinary Shares - Class A

Sagimet Biosciences Target Price

Analysts' average 12-month price target for Sagimet Biosciences is $18.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.09

Average Target Price

$18.00

62.3% upside

1 analysts in the last 4 months

High: $18 | Low: $18

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-09	BarclaysEliana Merle	$18	62.3% upside
2026-01-27	BarclaysEliana Merle	$8	27.9% downside
2024-06-28	Goldman SachsAndrea Tan	$6	45.9% downside

Sagimet Biosciences (SGMT) FAQ

As of the most recent data, SGMT shows a target price of $18. Scroll down for historical charts and peer comparison views.

If Sagimet Biosciences moved to the average analyst target of $18, shares would be roughly 62.3% higher than $11.09. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Sagimet Biosciences's earnings trajectory.

Besides this target price page, Stockcircle has Sagimet Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $18) with ownership activity and broader fundamentals.